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Abstract
Introduction—Black and Hispanic men are diagnosed with more HPV-related cancers and at 
later stages compared to other racial/ethnic groups. Physician communication with men about 
HPV vaccination may be beneficial to increasing HPV vaccinations and decreasing HPV 
transmission. The purpose of this study was to examine HPV and HPV vaccine awareness among 
men by race, and the association between trust in cancer information from physicians and ever 
hearing about HPV and the HPV vaccine.
Methods—U.S. adult males (age 18+) were identified from the 2014 Health Information 
National Trends Survey (HINTS) (n = 1203). Binomial logistic regression models assessed the 
influences of race/ethnicity and trust of cancer information from physicians on men having heard 
of HPV and the HPV vaccination.
Results—Approximately 50% of the sample had never heard of HPV and 53% had never heard 
of the vaccine. Black men were less likely to know that HPV is sexually transmitted compared to 
White and Hispanic men (p < 0.001). Hispanic and Black men were less likely to have heard about 
the HPV vaccine when compared to White men (p < 0.001). Additionally, Hispanic men were less 
likely to trust a doctor about cancer information compared to White and Black men (p < 0.001).
Conclusion—Findings highlight the lack of awareness about HPV among men. Furthermore, 
statistically significant racial/ethnic differences were found in HPV vaccine knowledge and trust in 
receiving cancer information from physicians. Future interventions should include community-
based approaches and improved physicians' HPV-related communication to increase knowledge 
and uptake of the HPV vaccine.
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Nearly 80 million people in the U.S. are infected with at least one strain of the Human 
papillomavirus (HPV) making it the most common sexually transmitted infection [1]. Many 
concerns associated with HPV are related to women, due to the association of HPV and 
cervical cancer, but HPV can also cause a significant cancer concern among men. HPV 
infections are the cause of anogenital cancers and warts in women and men [2]. The 
incidence of HPV-linked cancers such as, oropharyngeal and anal cancers, are increasing 
among men [3].
Racial and ethnic minority men are disproportionately affected by HPV-associated cancers 
and are diagnosed at later stages [4,5]. Anal cancer incidence rates are highest among Black 
men [3]. Additionally, Hispanic men have higher rates of penile cancer than non-Hispanic 
men [3]. Compared to White men, a recent investigation found that a greater proportion of 
Black men reported ever having had symptoms of HPV, and were less knowledgeable about 
HPV than White men [5]. Even in male populations at greatest risk, such as HIV-infected 
men and men who have sex with men (MSM), previous findings have indicated HPV 
knowledge deficits [6,7].
HPV awareness, knowledge, and vaccine uptake among men have been low [8–10]. 
Currently, there are three HPV vaccines available in the U.S., varying slightly in protection, 
cost, and target population for men between ages 9 and 27. HPV vaccination among males 
has demonstrated high levels of immunogenicity and reductions in genital lesions and 
precancerous anogenital lesions [11]. Underuse of HPV vaccination among men in the U.S. 
is a missed opportunity to prevent cancer. Studies indicate that parents' decisions about HPV 
vaccination of their sons are determined by its perceived benefits and risks, provider 
knowledge and recommendation, and parental beliefs [12–14]. Parents of younger children 
with information about the vaccine are more likely to allow vaccination than parents without 
information [15,16].
There are many reasons why HPV and HPV vaccine awareness and knowledge may be low 
among men. Of the many factors that influence HPV vaccination, the role of health care 
providers is the most influential [10,17,18]. However, males receive fewer recommendations 
for the HPV vaccine from health care providers and men who are ethnic and racial 
minorities do not trust information from physicians [19,20]. Although ethnic and racial 
minority men experience HPV-related disparities, few studies have concurrently examined 
HPV knowledge, the HPV vaccine and the trust in information from health care providers 
among this population [5,10,21,22].
Therefore the purpose of this study is to: (1) assess awareness of men about HPV and HPV 
vaccine by race/ethnicity and (2) examine the association of trust in information from 
physicians about cancer and ever hearing about HPV and the HPV vaccine. Understanding 
these factors is needed to inform educational interventions that may decrease patient-
provider mistrust, increase uptake of HPV vaccine and decrease disparities in HPV-related 
cancers among men.
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Data was obtained from the 2014 National Cancer Institute (NCI) Health Information 
National Trends Survey (HINTS), a national, population-based, cross-sectional survey of 
adults 18 years of age and older who reside in the United States and its territories. The 
dataset is available to the public online by accessing http://hints.cancer.gov. Survey data 
were collected via self-administered mail questionnaire. The HINTS provides state-level 
data for measuring the use of health information and healthy behaviors with a primary focus 
on cancer prevention and control. The total population sample was 1424 males. Since 
sample sizes of the other male racial/ethnic groups were small or the racial/ethnic group was 
not indicated, this study only included White, Black and Hispanic men ultimately reflecting 
a sample size of 1203.
2.2. Study variables
Dependent variables—The dependent variables in this study were whether participants 
ever heard of HPV and whether participants ever heard of the HPV vaccine, Gardasil. To 
assess whether the participants were aware of HPV, this study used the item “Have you ever 
heard of HPV? HPV stands for Human Papillomavirus. It is not HIV, HSV, or herpes” (yes/
no). To assess whether the participants were aware of the HPV vaccine, this study used the 
item “Before today, have you ever heard of the cervical cancer vaccine or HPV shot?” (yes/
no).
Independent variables—There was a 7-category race and ethnicity pre-recoded variable 
in the HINTS dataset of which the 3 groups of interest were selected out (White, Black, 
Hispanic). Trust in information from a physician was assessed with the item “How much 
would you trust information about cancer from a doctor?” (Not at all to A little/Some/A lot).
Control variables—Several sociodemographic variables were controlled for in the 
analysis including age, income, education, marital status, and health insurance status. 
Participants' age (in years) was treated as a continuous variable. Other variables were 
categorized as follows: Income ($0–$34,999/$35,000–$74,999/$75,000–$99,999/ $100,000 
or more); education (High school or less/Some college or post high school training/College 
or post graduate training); and employment status (Employed/Unemployed/Retired). The 
marital status of participants were married, divorced, widowed, separated, never married, or 
a member of an unmarried couple. This variable was dichotomized into Married (Married, 
Living as married) and Unmarried (Divorced, Widowed, Separated, Never married). To 
determine participants' health insurance status, we used the item “Do you have any kind of 
health care coverage, including health insurance, prepaid plans such as HMOs, or 
government plans such as Medicare?” (yes/no). Participants were also asked “Is there a 
particular doctor, nurse, or other health professional that you see most often?” (yes/no). To 
assess whether men knew that HPV could be sexually transmitted, an item asked “Do you 
think that HPV is a sexually transmitted disease (STD)?” (yes/no).
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Modal imputation was used to address missing data for dichotomous and categorical 
variables. Mean imputation was used to address missing data in continuous variables. The 
analyses for this study proceeded in two steps. First, Chi-square tests were used to assess 
bivariate differences between men who have heard of HPV and those who had not by race/
ethnicity, and differences between men who have heard of the HPV vaccine and those who 
had not by race/ethnicity. Secondly, binomial logistic regression analyses were performed 
for having heard of HPV and having heard of HPV vaccination (shown in Tables 3 and 4, 
respectively). Model 1 shows only the control variables and the dependent variable. In model 
2, race/ethnicity was added to the model and in model 3 trust of cancer information from the 
doctor was included in the model without the race/ethnicity variables. Lastly, model 4 is the 
full model. The models were compared using Akaike's Information Criterion (AIC) statistic 
for best model fit. Due to high collinearity between the dependent variable (Have you ever 
heard of HPV) and the independent variable (Do you think that HPV is a sexually 
transmitted disease), the latter was not included in the binomial logistic regression models. 
The data were managed and analyses were conducted using SPSS version 18.0.
3. Results
3.1. Univariate/bivariate results
Descriptive statistics are shown in Table 1. The mean age of the sample was 56.79 years (SD 
= 15.43). Most of the men in the sample were insured (91%), White (70%), and married or 
in a married-like relationship (61%). Most had college/post graduate education (43%), were 
employed (51%), and had a household income of $35, 000–$74,999 (32%). In addition, 
most of the sample indicated that they had a regular health provider (71%). However, 33% 
did not have knowledge that HPV was a sexually transmitted disease, 51% had never heard 
of HPV, and 53% were not aware of the HPV vaccine.
Table 2 shows the descriptive statistics by race/ethnicity, HPV knowledge, and level of trust 
of cancer information from a doctor.
White men (76.1%) were most likely to have a regular provider (p < 0.001), and to have 
heard of the HPV vaccine (50.1%) (p < 0.001). Black men (45.2%) were the least likely to 
know that HPV is transmitted sexually (p < 0.001) and both Black (35.3%) and Hispanic 
men (34.3%) were less likely to have heard of the HPV vaccine compared to White men (p < 
0.001).
With respect to the level of trust, Hispanic men (58.6%) were the least likely to trust 
information about cancer from a doctor. Men who had some or a lot of trust in cancer 
information from a doctor were more likely to have heard of the HPV vaccine, married, 
insured, have a regular provider, have a college or higher education, and have an income of 
100,000 or more compared to men who did not trust cancer information from a doctor a little 
or not at all (p < 0.001). Additionally, men who were retired and men whose income was 
$35,000–$74,000 were more likely to trust information about cancer from doctors a lot. Men 
who were not employed, had a high school education or less, and low-income were more 
likely to not trust information about cancer from a doctor at all or a little.
Cooper et al. Page 4













3.2. Binomial logistic regression analyses
Table 3 shows the results from binomial logistic regression analyses for predicting having 
heard of HPV. Models 1 and 2 with only the control variables and race/ethnicity, 
respectively, are similar in variables that are significant in predicting having heard of HPV. 
Having a regular provider, at least some college/post high school training, a household 
income of $100,000 or more, ages 9– 27 in the home, and mean age were all predictive of 
having heard of HPV. In Model 3, having a regular provider was no longer significant 
suggesting that the level of trust in information from the doctor modified having a regular 
provider. In addition, the AIC shows that this model is better than Model 1. Model 4, the full 
model, proved to be the best fit of all the models according to the AIC. Men who had some 
college/post high school training and college/post graduate had 43.8% and 97.6% higher 
odds, respectively, of having heard of HPV than men with a high school or less education. 
Men who lived in households with an income of $100,000 or more had 71.4% higher odds 
than men who lived in households with income less than $34,999, and men who lived with 
family member(s) between ages 9 and 27 had 33.9% higher odds of having heard of HPV.
Table 4 shows the results from a binomial logistic regression analyses for predicting having 
heard of the HPV vaccine. Model 2 shows that Black men had 34.8% less odds and Hispanic 
men had 43.6% less odds of hearing heard of the HPV vaccine than White men. This was a 
better fit model than model 1 according to the AIC statistic. Model 3 shows that when 
including the “trust of cancer information from the doctor” variable, the model was similar 
to model 1 and less parsimonious. Model 4, the full model, was the best fit model, according 
to the AIC statistic. This model shows that when controlling for demographic variables, 
insurance status, and having a regular provider, Black and Hispanic men are 35% and 43%, 
respectively, less likely to have heard of the HPV vaccination.
4. Discussion
This study demonstrated findings that are similar to other studies indicating that men have 
low levels of knowledge and awareness about HPV and the HPV vaccine [23–25]. These 
studies indicated that, overall, men have not heard of HPV, particularly men of minority 
ethnic groups. About half of the men (49%) heard about HPV and 45% lacked awareness of 
the HPV vaccine. The current study extends the literature by highlighting the disparities in 
knowledge about (1) HPV among a cohort of solely men (2) disparities in knowledge about 
the HPV vaccine by race/ethnicity, and (3) the level of trust these men have in cancer 
information from physicians. Analyses showed that White men had greater odds of having 
heard of the HPV vaccine and knowing that HPV is transferred through sexual activity when 
compared to Black and Hispanic men.
While this study represented analysis identifying noteworthy racial/ethnic disparities, more 
attention on increasing the HPV knowledge and awareness of specific sub-groups, such as 
male sexual minorities and HIV-infected men, is vital, representing other layers of identity 
that are often underrepresented in awareness, prevention and knowledge promotion 
strategies. Other potential subgroups of men who may be at increased risk of HPV infection 
and perceived to be “low risk” include men who were married early, newly divorced men 
who are dating again, men who have had few partners, or men who use contraception 
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regularly. Awareness of HPV and the HPV vaccine ultimately contribute to uptake of the 
HPV vaccine [26]. It is imperative to revise the messaging around HPV vaccination. HPV 
research largely focuses on cervical cancer prevention through HPV vaccination, essentially 
feminizes HPV [10,27] and erroneously characterizes HPV as an infection that do not effect 
men who have sex with men (MSM) or men who have sex with women only (MSW) 
[28,29]. MSM are at an increased risk of developing anal cancer from HPV infection and 
have poorer knowledge about HPV compared to women [24,30,31]. Furthermore, MSW are 
less knowledgeable about HPV than MSM [32]. Emerging research examining the benefits 
of HPV vaccine in adult males further emphasizes the significance of prioritizing related 
dissemination and awareness strategies for this population [33]. Other investigations, 
however, indicate that Black and Hispanic adolescent males and their parents place more 
importance on HPV vaccinations compared to White adolescent males and their parents 
[34,35]. Due to the well-recognized burden of health disparities that exist in HPV-associated 
cancers and uncompromised access to cancer screening and prevention services later in life 
particularly among racial and ethnic minorities, primary prevention, like the vaccine, is 
critical [4].
Results of this study demonstrate that racial and ethnic minority men represent unique 
priority populations for increased awareness and intervention towards HPV vaccination. The 
differences in HPV knowledge may be a result of Black and Hispanic men lacking a regular 
provider that may inform them about HPV. The disparity in HPV knowledge may also be 
due to the level of trust of information from physicians. Analysis in this study indicated that 
Hispanic men were the least trusting of information about cancer from physicians. The lack 
of trust in providers expressed by older Hispanic men may be a critical issue for their own 
health but it may also deter relaying HPV-related information to younger males.
Other studies have shown a lack of trust in physicians among Black men as well [36,37] 
which may lead to a lack of trust in medical information and medical non adherence. This 
study suggests that an increase in provider recommendations, through culturally tailored 
strategies may increase HPV vaccinations among men.
Given that men generally lacked knowledge about HPV and lacked trust in information from 
physicians, other culturally appropriate avenues to increase HPV knowledge and awareness 
for this group should be explored. Though the recommended age for HPV vaccination is 
between ages 9 and 27, the lack of knowledge about HPV and HPV vaccine among males of 
all ages is an issue that may perpetuate a recurring cycle of increased risk for HPV infection. 
In this study, Black and Hispanic men were more likely to live with someone who was 
between the recommended ages. Educating male parents about HPV vaccine increases the 
likelihood of early vaccination [34,38] among Blacks and Latinos, and people that discuss 
vaccinations within social networks have been linked to an increase in the likelihood to 
make the decision to receive vaccination [35]. Therefore, the onus for disseminating HPV 
information should not be only on the provider. Men who are above the recommended age 
may be in a unique and significant position to optimize awareness of risks and increase 
vaccinations.
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Health organizations and institutions should partner with community organizations and 
community leaders to assist in community-based participatory research to disseminate 
information about HPV infection prevention that is racially, culturally, age, and gender 
appropriate to address HPV knowledge and vaccination adherence disparities [39]. 
Interventions that involve both clinical and non-clinical community linkages may be a cost-
effective way to build trusting relationships between men in the community, providers and 
other health professionals. Community health workers may also be a conduit for HPV 
vaccine information, however it would be important to have providers willing to partner to 
ensure that the proper information and messages are delivered to prioritized communities 
and to enhance trust between providers and potential patients.
4.1. Limitations
This study has acknowledged limitations that should be addressed in subsequent studies. 
First, this is a cross-sectional study, which is only a snapshot of the sample population. 
Therefore, while the study showed the association between the independent variables and the 
dependent variables, a causal relationship could not be confirmed. Second, the data collected 
was self-reported. Racial/ethnic groups have been found to have respondent bias (i.e. social 
desirability) resulting in an analysis that is less accurate [40]. Additionally, the number of 
Black and Hispanic men in the sample was relatively low compared to White men. 
Literature indicates differences in HPV associated cancers among MSM and MSW, however, 
the HINTS dataset did not ask about sexual orientation. Therefore, possible differences in 
knowledge about HPV and HPV vaccine by sexual orientation could not be measured. HPV 
vaccine is a recent prophylactic made available and recommended to males. With continued 
research and HPV vaccine education, it is possible that men in this 2014 dataset may have a 
lower level of awareness than men have today. Finally, the sample for this study had a higher 
education and income level than the national average, which may skew the findings in a 
direction that is more favorable with respect to HPV and vaccination knowledge and trust of 
cancer information from a physician.
5. Conclusion
HPV knowledge and awareness should be increased among males to decrease the risk of 
infection that may lead to the development of HPV-related cancers. Specifically, Black and 
Hispanic men are less aware than White men about HPV and HPV vaccination, setting the 
stage for health disparities. Higher levels of distrust of information from physicians among 
Hispanic men and Black and Hispanic men's lack of a regular health provider indicate that 
community-based educational methods should be used.
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Table 1
Descriptive statistics
Mean/proportion Standard deviation Minimum Maximum
Dependent variables
 Heard of HPV 0.49 – 0 1
 Have not heard of HPV 0.50 – 0 1
 Aware of HPV vaccine 0.45 – 0 1
 Not aware of HPV vaccine 0.53 – 0 1
Independent variables
 Trust Physician
  A little/not at all 0.07 – 0 1
  Some 0.22 – 0 1
  A lot 0.69 – 0 1
 White non-Hispanic 0.70 – 0 1
 White non-Hispanic 0.14 – 0 1
 Hispanic 0.16 – 0 1
Control variables
 Insured 0.91 – 0 1
 Not insured 0.09 – 0 1
 Regular provider 0.71 – 0 1
 No regular provider 0.27 – 0 1
 Married 0.61 – 0 1
 Not married 0.37 – 0 1
 Employed 0.51 – 0 1
 Not Employed 0.14 – 0 1
 Retired 0.32 – 0 1
Income
  $0–34,999 0.30 – 0 1
   $35,000–$74,999 0.32 – 0 1
   $75,000–$99,999 0.13 – 0 1
   $100,000 or more 0.24 – 0 1
 High School or less 0.25 – 0 1
 Some college/post high school training 0.32 – 0 1
College/post graduate 0.43 – 0 1
 * Knows HPV is a STD 0.65 – 0 1
 * Does not know HPV is a 0.33 – 0 1
 STD
 Age 9–27 in home 0.37 – 0 1
 Age 9–27 not in home 0.62 – 0 1
Age (continuous) 56.79 15.43 18 95
N = 1203.
*
Note: indicates lower number of participants for the item (n = 594) due to a skip pattern within the questionnaire.



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Vaccine. Author manuscript; available in PMC 2017 July 16.
